Velsipity is a medicine used to treat people aged 16 years and over with ulcerative colitis (a disease causing inflammation and ulcers in the lining of the bowel). It is used to treat moderately to severely active disease when standard treatment or biological agents (medicines made by cells grown in a laboratory) have not worked well enough or cannot be used by the patient. Velsipity contains the active substance etrasimod.
Therapeutic Indication
Velsipity is indicated for the treatment of patients 16 years of age and older with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy, or a biological agent.
Therapeutic Area (MeSH)
ATC Code
L04AE05
ATC Item
N/A
Pharmacotherapeutic Group
Immunosuppressants
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Etrasimod arginine | N/A | Etrasimod arginine |
EMA Name
Velsipity
Medicine Name
Velsipity
Aliases
N/ANo risk management plan link.
